Anvisa prohibits slimming pen from Paraguay
Measure was published this Wednesday in the Official Gazette
TL;DR
- Anvisa has prohibited the T36 slimming pen, a GLP-1 receptor agonist from Paraguay.
- The medication lacks sanitary registration and its safety and efficacy have not been evaluated in Brazil.
- Anvisa previously banned the sale of unregistered slimming pens from the website www.gopharma.shop.
- The agency emphasized that only regulated pharmacies can sell medications through official physical or digital channels.
- Products bought outside official channels have no guarantee of origin, composition, or conservation, compromising quality, safety, and efficacy.